Table 1.
Baseline prevalence of metabolic syndrome defined by WHO and ATP-III criteria and components in older adults without known CHD
| Yes | No | |
|---|---|---|
| Metabolic syndrome defined by WHO criteria | ||
| n | 44 | 248 |
| Prevalence of WHO components (%) | ||
| Impaired glucose metabolism (type 2 diabetes, impaired fasting glucose [110–125 mg/dl] or impaired glucose tolerance [140–199 mg/dl]) | 100.0 | 5.2 |
| Obesity (BMI >30 kg/m2 and/or waist-to-hip ratio >0.9 for men and >0.85 for women) | 97.7 | 55.2 |
| High triglycerides (≥150 mg/dl) | 56.8 | 25.8 |
| Low HDL cholesterol (<35 mg/dl for men and <39 mg/dl for women) | 11.4 | 1.2 |
| Hypertension (≥140/90 mmHg or use of antihypertensive drugs) | 84.1 | 37.1 |
| Albuminuria (urinary albumin excretion rate ≥20 μg/min or albumin-to-creatinine ratio ≥30 mg/g) | 9.1 | 2.8 |
| Metabolic syndrome defined by ATP-III criteria | ||
| n | 40 | 298 |
| Prevalence of ATP-III components (%) | ||
| Fasting plasma glucose >110 mg/dl | 47.5 | 14.8 |
| Abdominal obesity (waist circumference >102 cm for men and >88 cm for women) | 72.5 | 14.1 |
| High triglycerides (≥150 mg/dl) | 80.0 | 22.5 |
| Low HDL cholesterol (<40 mg/dl for men and <50 mg/dl for women) | 80.0 | 7.4 |
| Hypertension (≥130/85 mmHg or use of antihypertensive drugs) | 90.0 | 51.7 |